Study guide

3.1 Acute Coronary Syndrome & Myocardial Infarction

AACN CCRN Adult

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Strategy

1.1 Exam Facts, Format & the Synergy Model Blueprint 1.2 How to Study & Test-Taking Strategy

2 Cardiovascular I — Hemodynamics & Shock

2.1 Hemodynamic Monitoring & Values 2.2 Shock States 2.3 Vasoactive & Inotropic Pharmacology

3 Cardiovascular II — ACS, Heart Failure & Dysrhythmias

3.1 Acute Coronary Syndrome & Myocardial Infarction 3.2 Heart Failure & Mechanical Circulatory Support 3.3 Dysrhythmias, ECG & ACLS

4 Respiratory I -- Failure, ABGs & Acute Conditions

4.1 Respiratory Failure & ABG Interpretation 4.2 Acute Respiratory Distress Syndrome (ARDS) 4.3 Pulmonary Embolism, Pneumothorax, COPD & Asthma

5 Respiratory II — Mechanical Ventilation

5.1 Ventilator Modes & Settings 5.2 Weaning, Airway & Ventilator Complications

6 Endocrine Emergencies

6.1 Glycemic Emergencies 6.2 DI, SIADH, Thyroid & Adrenal Crises

7 Renal & Genitourinary

7.1 Acute Kidney Injury, Electrolytes & Acid-Base 7.2 Renal Replacement Therapy

8 Gastrointestinal

8.1 GI Bleeding & Acute Hepatic Failure 8.2 Pancreatitis, Acute Abdomen, Bowel Ischemia & Nutrition

9 Hematology, Immunology & Integumentary

9.1 Coagulopathies & Transfusion Therapy 9.2 Immunocompromise & Oncologic Emergencies 9.3 Integumentary - Wounds & Pressure Injuries

10 Neurological I — Stroke, TBI & ICP

10.1 Ischemic & Hemorrhagic Stroke 10.2 Traumatic Brain Injury & ICP Management 10.3 Seizures, Status Epilepticus & Neuromonitoring

11 Neurological II & Musculoskeletal

11.1 Spinal Cord Injury & Neuromuscular Emergencies 11.2 Encephalopathy, Coma & Brain Death 11.3 Musculoskeletal

12 Behavioral & Psychosocial

12.1 Delirium, Agitation, Sedation & Pain 12.2 Substance Withdrawal, Psychiatric Emergencies & Patient Safety

13 Multisystem I — Sepsis & MODS

13.1 Sepsis & Septic Shock 13.2 Multi-Organ Dysfunction Syndrome 13.3 Resuscitation Priorities & Rapid Response

14 Multisystem II — Trauma, Burns & Toxicology

14.1 Trauma & Burns 14.2 Toxicology, Anaphylaxis & Temperature Emergencies

15 Synergy Model, Advocacy & Caring

15.1 The AACN Synergy Model 15.2 Advocacy & Moral Agency 15.3 Caring Practices

16 Collaboration, Systems Thinking & Diversity

16.1 Collaboration & Interdisciplinary Teamwork 16.2 Systems Thinking 16.3 Response to Diversity & Facilitation of Learning

17 Clinical Inquiry, Ethics & End-of-Life

17.1 Clinical Inquiry & Evidence-Based Practice 17.2 Ethical/Legal Issues, End-of-Life & Goals of Care

3.1 Acute Coronary Syndrome & Myocardial Infarction

Key Takeaways Explain This Topic AI

STEMI requires ST elevation greater than or equal to 1 mm in two contiguous leads (V2-V3: greater than or equal to 2 mm men over 40, 1.5 mm women); NSTEMI has positive troponin without persistent ST elevation; unstable angina has negative troponin.

ST elevation in II, III, and aVF localizes to the right coronary artery (inferior wall); always obtain right-sided lead V4R to detect RV infarction.

Primary PCI door-to-balloon goal is 90 minutes or less (120 if transfer); fibrinolysis door-to-needle goal is 30 minutes or less when PCI is unavailable within 120 minutes.

Aspirin 162-325 mg chewed is the single most important early ACS drug; oxygen is given only when SpO2 is below 90%.

RV infarction is preload-dependent: treat hypotension with fluids and avoid nitroglycerin, diuretics, and morphine that reduce preload.

Last updated: July 2026

Acute Coronary Syndrome: The Ischemic Spectrum

Acute coronary syndrome (ACS) describes a continuum of myocardial ischemia caused by acute atherosclerotic plaque rupture with thrombus formation in a coronary artery. The CCRN tests ACS as three overlapping diagnoses distinguished by the electrocardiogram (ECG) and cardiac troponin : unstable angina, non-ST-elevation myocardial infarction (NSTEMI), and ST-elevation myocardial infarction (STEMI).

Unstable angina (UA) — ischemic chest pain at rest or in a crescendo pattern; the ECG may show ST depression or T-wave inversion, but troponin is negative . There is ischemia without measurable myocardial cell death.

NSTEMI — a partial (subtotal) occlusion that produces necrosis. Troponin is positive ; the ECG shows ST depression and/or T-wave inversion but no persistent ST elevation .

STEMI — a complete, transmural occlusion . Troponin is positive and the ECG shows new ST elevation or a new left bundle branch block. STEMI is a time-critical emergency requiring immediate reperfusion.

ST-Elevation Criteria and ECG Localization

STEMI is defined as ST elevation greater than or equal to 1 mm in two contiguous leads , except in V2-V3, where the thresholds are greater than or equal to 2 mm in men 40 and older, 2.5 mm in men under 40, and 1.5 mm in women (Fourth Universal Definition of MI). The lead pattern localizes the infarct and predicts the culprit vessel — a classic CCRN mapping item.

  • ECG Leads Wall Culprit Coronary Artery Watch For
  • V1-V2 Septal LAD (proximal) Bundle branch/AV block
  • V3-V4 Anterior LAD Pump failure, cardiogenic shock
  • V1-V4 Anteroseptal LAD (large) Highest mortality
  • I, aVL, V5-V6 Lateral Left circumflex (LCx) or diagonal Extension of anterior/inferior
  • II, III, aVF Inferior Right coronary artery (RCA) RV infarct, bradycardia, heart block
  • Tall R + ST depression V1-V3 Posterior RCA/LCx (PDA) Missed if only 12-lead read
  • V4R (right-sided) Right ventricle Proximal RCA Preload-dependent hypotension

The inferior clue is tested repeatedly: ST elevation in II, III, and aVF points to the RCA . Because the RCA also supplies the SA and AV nodes and the right ventricle, inferior STEMI carries a high risk of RV infarction and bradydysrhythmias/heart block . Obtain right-sided leads (V4R) with every inferior MI; ST elevation in V4R confirms RV involvement.

Biomarkers

Cardiac troponin (I or T) is the most sensitive and specific marker of myocardial injury. High-sensitivity troponin begins to rise within 1-3 hours , peaks at 12-24 hours , and may remain elevated 7-14 days. Serial sampling with a 0/1-hour or 0/3-hour protocol improves early rule-in/rule-out. A single value is never diagnostic alone; a rise and/or fall in the appropriate clinical context is required. CK-MB has been largely supplanted by troponin but normalizes faster, which makes it useful for detecting re-infarction .

Clinical Presentation and Risk Stratification

Classic ACS presents with substernal chest pressure radiating to the left arm or jaw, accompanied by diaphoresis, nausea, and dyspnea. Atypical presentations are common and must never be dismissed in women, older adults, and patients with diabetes , who may report only fatigue, epigastric discomfort, or isolated dyspnea (a silent MI). For NSTEMI and unstable angina, validated risk scores such as TIMI and GRACE stratify short-term risk of death and re-infarction; higher scores favor an early invasive strategy with angiography within 24 hours. A rising troponin, dynamic ECG changes, hemodynamic instability, or refractory ischemia all push toward urgent catheterization rather than a conservative ischemia-guided approach.

Pharmacologic Therapy: Beyond MONA

The classic mnemonic MONA (Morphine, Oxygen, Nitroglycerin, Aspirin) is outdated in its priority order. Current early management is:

Aspirin 162-325 mg chewed immediately — the single most important early drug.

P2Y12 inhibitor — ticagrelor, prasugrel, or clopidogrel (dual antiplatelet therapy).

Anticoagulation — unfractionated heparin or a low-molecular-weight heparin.

Nitroglycerin for ischemic pain/hypertension — contraindicated in RV infarction, hypotension (SBP under 90), or recent phosphodiesterase-5 inhibitor (sildenafil) use.

High-intensity statin started early.

Beta-blocker within 24 hours only if there is no heart failure, shock, bradycardia, or high-degree block.

Oxygen only when SpO2 is below 90% — routine oxygen provides no benefit and may harm.

Morphine is now reserved for refractory pain because it can blunt and delay P2Y12 absorption.

Reperfusion — The Clock That Matters

For STEMI , reperfusion is time-driven:

Primary PCI (percutaneous coronary intervention) is preferred, with a door-to-balloon goal of 90 minutes or less (120 minutes or less if the patient must be transferred to a PCI-capable center).

Fibrinolysis is used when PCI cannot be achieved within 120 minutes, with a door-to-needle goal of 30 minutes or less . Absolute contraindications include prior intracranial hemorrhage, ischemic stroke within 3 months, active internal bleeding, and suspected aortic dissection.

NSTEMI and UA are managed with an early invasive or ischemia-guided strategy; fibrinolytics are never given for NSTEMI .

Complications

Mechanical and electrical complications the CCRN emphasizes: cardiogenic shock (the leading cause of in-hospital MI death), papillary muscle rupture causing acute mitral regurgitation and flash pulmonary edema, ventricular septal rupture (new harsh holosystolic murmur and step-up in oxygen saturation), free-wall rupture with tamponade , LV aneurysm , pericarditis (including late Dressler syndrome), and reperfusion or ischemic dysrhythmias . RV infarction presents with the triad of hypotension, clear lungs, and elevated jugular venous pressure ; because the failing RV is preload-dependent , treat with fluid loading and avoid nitrates, diuretics, and morphine . A frequent trap: giving nitroglycerin for chest pain in an inferior/RV STEMI, which collapses preload and precipitates profound hypotension.